Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vaginal and gut microbiomes are complex ecological communities of microorganisms, including bacteria, fungi, and viruses, that reside in the human body and maintain a symbiotic relationship with the host. The gut microbiome is essential for metabolic processes, such as the fermentation of non-digestible carbohydrates into short-chain fatty acids, and plays a pivotal role in the development and regulation of the mucosal immune system (Lynch & Pedersen, 2016, NEJM). In contrast, a healthy vaginal microbiome is typically characterized by low diversity and a predominance of Lactobacillus species, which produce lactic acid to maintain a low pH and inhibit the growth of pathogens (Ravel et al., 2011, PNAS). Dysbiosis in these environments is associated with numerous pathologies, including inflammatory bowel disease (IBD), metabolic syndrome, bacterial vaginosis, and increased susceptibility to sexually transmitted infections (NIH Human Microbiome Project). Therapeutic interventions targeting these microbiomes, such as probiotics, prebiotics, and live biotherapeutic products like SER-109 or Lactin-V, aim to restore microbial homeostasis and host-microbe interactions to treat or prevent disease (Cohen et al., 2020, NEJM).
Restoration of microbial homeostasis, competitive inhibition of pathogens, production of antimicrobial metabolites, and modulation of host metabolic and immune pathways.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vaginal and gut microbiome.